Leadership & Staff

Staff Leadership

        • David Arons

          David F. Arons, JD

          Chief Executive Officer

          David Arons is the Chief Executive Officer of the National Brain Tumor Society. He previously served in leadership and external positions at the American Cancer Society in Minnesota, the Center for Lobbying in the Public Interest and at Independent Sector. As an attorney, he previously represented patients facing disabilities and serious health conditions. He is the author of several books, including Power in Policy: A Funder’s Guide to Advocacy and Civic Participation, Strengthening Nonprofit Advocacy, and A Voice for Nonprofits. He serves on the National Cancer Institute’s Council of Research Advocates and Clinical Trials Advisory Committee. In 2016, Mr. Arons was named to the Blue Ribbon Panel of experts selected to help advise the National Cancer Moonshot, led by former Vice President Joseph Biden.

        • Gallucci

          Steve Gallucci

          Chief Financial Officer

          Steve Gallucci is the Chief Financial Officer of the National Brain Tumor Society. Steve brings to NBTS over twenty years of experience in financial leadership. He has served non-profits in human services, healthcare, and education, and for-profit organizations in biotech, professional services, and media. He has led organizations from startup to dramatic growth to acquisitions. Most recently, Steve served as a consulting CFO, providing expert council to senior leaders and Boards of Directors. Steve is a licensed CPA and received his MBA from Cornell University.

        • Hall

          Lauren Hall, CFRE

          Chief Development Officer

          Lauren Hall is the Chief Development Officer at the National Brain Tumor Society. A senior development professional with nearly two decades of experience at some of the world’s leading institutions – including Dana-Farber Cancer Institute, the University of Pennsylvania, and Brigham and Women’s Hospital – Lauren has served as a frontline fundraiser for three multibillion-dollar campaigns. She has secured transformative funding from individuals, corporations, and foundations, built and managed boards and committees, and led highly successful fundraising teams. She previously served as Assistant Vice President of Development at Brigham and Women’s Hospital, where she directed fundraising for the neurosciences and played a key role in launching the Ann Romney Center for Neurologic Diseases.

        • Leach

          Danielle Leach, MPA

          Chief of Community & Government Relations

          Danielle Leach is the Chief of Community & Government Relations at the National Brain Tumor Society. Danielle brings outstanding experience, leadership, and a track record of accomplishment to NBTS from more than two decades working in healthcare and cancer patient advocacy. Most recently, she served as Senior Director of Advocacy and Government Relations at St. Baldrick’s Foundation. Previously, she held leadership positions at the American Cancer Society, Ovarian Cancer National Alliance, and Strang Cancer Prevention Center. Additionally, she currently serves as the Co-Chair of the Alliance for Childhood Cancer, as a member of the National Cancer Institute’s (NCI) National Council of Research Advocates, and as a member of the NCI’s Pediatric and Adolescent Solid Tumor Steering Committee. She served on Vice President Biden’s Cancer Moonshot, as part of the Pediatric Cancer Working Group, and was recognized in 2018 with the ASCO Partners in Progress award and the Rare Disease Legislative Advocates Rare Voice Award.

        • Nugent

          Gina Nugent

          Chief Communications Officer

          Gina Nugent is the Chief Communications Officer at the National Brain Tumor Society. Gina brings more than 20 years of experience developing strategic communications programs within the biopharmaceutical industry. She most recently led a successful consulting practice providing strategic counsel and integrated communication programs to both emerging and established biopharmaceutical clients. Prior to consulting, Gina held senior communication roles at some of the industry’s most innovative biotech organizations, including Millennium Pharmaceuticals, CombinatoRx, and Wyeth Research. She earned an M.S. in Communications Management from Simmons College and a B.A. in Marketing Management from Northeastern University and is a member of the Healthcare Business Women’s Association, Women in BIO and MassBio.

        • Tanner

          Kirk Tanner, Ph.D

          Chief Scientific Officer

          Kirk Tanner is the Chief Scientific Officer at the National Brain Tumor Society. Kirk is an oncology research leader with two decades experience in discovery and development projects and programs resulting in multiple clinical candidate therapies and investigational new drugs. Formerly, he was the Research Oncology Disease Area Expert and Senior Director at Vertex Pharmaceuticals. As CSO, Kirk leads National Brain Tumor Society’s research program that aims to catalyze treatment development through philanthropic investment in medical research, engaging scientists, clinicians, patients and care partners in research programs. Kirk received his Ph.D. in chemistry from the University of California, San Diego and did post-doctoral training at Oregon Health Sciences University.

Back to top

Board of Directors

Officers

        • Sarah Durham

          Sarah Durham – Chair

          Sarah Durham is the Chair of the National Brain Tumor Society Board of Directors. She is the CEO of Big Duck, a communications firm that works exclusively with nonprofits experiencing significant growth and change. She was named a top fundraiser under 40 by Fundraising Success in 2006, and one of the most influential women in technology by Fast Company in 2010.

        • Thomas Rolof

          Thomas Roloff – Vice Chair

          Thomas Roloff is the vice chairperson of the National Brain Tumor Society. He is senior vice president of Information Technology & Business Transformation at Dell Technologies Corporation. He also attended the MIT Sloan School of Management where he earned an M.B.A. Mr. Roloff was also a vice president of EMC and chief operating officer at EMC Consulting. He has also held senior management positions at Perot Systems and HomeLife Medical. He earned his undergrad degree at Lafayette University and a masters degree at Virginia Tech University.

        • John Frishkopf

          John Frishkopf – Treasurer

          John Frishkopf is the Treasurer of the National Brain Tumor Society Board of Directors and the Chair of the Programs Committee. He is a founder of NewStar Financial, Inc. from which he recently retired as Treasurer and Head of Asset Management. Mr. Frishkopf joined the board of NBTS after his husband, now deceased, was diagnosed with glioblastoma. A graduate of MIT and MIT Sloan, John Frishkopf has spoken at conferences and has published on using financial engineering techniques to speed the drug discovery process.

        • Robert Burger

          Robert Burger – Clerk

          Robert Burger is the Clerk of the National Brain Tumor Society Board of Directors. He is also the Executive Director and Chief Operating Officer at the global intellectual property law firm of Sterne Kessler Goldstein & Fox headquartered in Washington, D.C. Rob is actively involved in other boards and earned his Bachelor of Arts from Miami University of Ohio, his Master’s degree from American University, and an MBA from Georgetown University. Rob’s aunt founded BTS, an NBTS legacy organization, after tragically losing her son Seth Harris Feldman to a Glioblastoma in December of 1988 (days before his 18th birthday).

Board Members

  • Dave Brown
  • Robert Corrao
  • David Donabedian
  • Amy Fenton
  • Evanthia Galanis, MD
  • Ryan Lang
  • Autumn McDonald
  • Chandri Navarro, Esq.
  • Dr. Edjah Nduom
  • Eric Olson, PhD
  • Stephen T. Sadler, JD
  • Liz Salmi
  • Michael Smith
  • Salo Zelermyer, JD

Co-Founder: G. Bonnie Feldman
The Brain Tumor Society

Co-Founder: Walter & Ellen Newman and David & Nora Plan
National Brain Tumor Foundatio

Emeritus Board Members

  • Michael Corkin
  • Richard Genderson
  • Ken Grey
  • Steve Karol
  • Sheila Killeen
  • Jeffrey Kolodin
  • Michael Nathanson, JD, LLM
  • Susan Pannullo, MD
  • Cord Schlobohm, DMD
  • Rabbi Eric B. Wisnia
  • Charles B. Wilson, MD (deceased)

Back to top

Advisors

Medical Advisory Board

  • Terri S. Armstrong, PhD, NP
    Neuro-Oncology Branch, National Cancer Institute
  • Dr. Stephen Brem, MD
    University of Pennsylvania
  • Timothy Cloughesy, MD, (Vice Chair)
    University of California, Los Angeles
  • Paul Fisher, MD
    Stanford University Medical Center
  • Sherry Fox, PhD, RN, CNRS
    Bon Secours Cancer Institute
  • Amar Gajjar, MD
    St. Jude Children’s Research Hospital
  • Mark Gilbert, MD
    Neuro-Oncology Branch, National Cancer Institute
  • Glenn Lesser, MD
    Wake Forest University Medical Center
  • Susan Pannullo, MD
    New York-Presbyterian Hospital/Weil Cornell Medical College
  • Scott Pomeroy, MD, PhD
    Boston Children’s Hospital
  • Liz Salmi
    Patient Researcher OpenNotes/Beth Israel Deaconess Medical Center
  • Jeffrey Wefel, PhD
    The University of Texas MD Anderson Cancer Center
  • Dr. Patrick Wen, MD, (Chair)
    Dana Farber Cancer Institute

Scientific Advisory Council

  • Yancey Gillespie, PhD (Chair)
    University of Alabama at Birmingham
  • Jill Barnholtz-Sloan, PhD
    Case Western Reserve University
  • Dan Cahill, MD, PhD
    Massachusetts General Hospital
  • Joseph Costello, PhD
    University of California, San Francisco
  • David Eisenstat, MD
    University of Alberta
  • Michael Lim, MD
    Johns Hopkins University
  • Duane Mitchell, MD, PhD
    University of Florida
  • Mario Suva, MD, PhD
    Massachusetts General Hospital
  • Ashley Sumrall, MD
    Levine Cancer Institute
  • Forest M. White, PhD
    Massachusetts Institute of Technology

Defeat GBM Strategic Scientific Advisory Council

  • Anna Barker, PhD
    Arizona State University
  • Mitchel S. Berger, MD, FACS, FAANS
    University of California, San Francisco
  • Lewis Cantley, PhD
    Weill Cornell Medical College
  • Webster Cavenee, PhD
    Ludwig Institute for Cancer Research, San Diego
  • William C. Hahn, MD, PhD
    Dana-Farber Cancer Institute
  • W.K. Alfred Yung, MD
    The University of Texas MD Anderson Cancer Center

Share